Hypertrophic remodeling of subcutaneous small resistance arteries in patients with Cushing's syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 12, 2009, Pages 5010-5018

  Rizzoni, Damiano ^a   Porteri, Enzo ^a   De Ciuceis, Carolina ^a   Rodella, Luigi F ^a   Paiardi, Silvia ^a   Rizzardi, Nicola ^a   Platto, Caterina ^a   Boari, Gianluca E M ^a   Pilu, Annamaria ^a   Tiberio, Guido A M ^a   Giulini, Stefano M ^a   Favero, Gaia ^a   Rezzani, Rita ^a   Rosei, Claudia Agabiti ^a   Bulgari, Giuseppe ^a   Avanzi, Daniele ^a   Rosei, Enrico Agabiti ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GROWTH FACTOR; HYDROCORTISONE; SUPEROXIDE;

ACROMEGALY; ADULT; ARTERY; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CUSHING SYNDROME; DEMOGRAPHY; ESSENTIAL HYPERTENSION; FEMALE; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MICROVASCULATURE; MORPHOMETRICS; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENOVASCULAR HYPERTENSION; SUBCUTANEOUS SMALL RESISTANCE ARTERY; SYSTOLIC BLOOD PRESSURE;

EID: 73249137996     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-1588     Document Type: Article

References (41)

1. Mulvany MJ, Aalkjaer C 1990 Structure and function of small arteries. Physiol Rev 70:921-961
2. Schiffrin EL 2004 Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment. Am J Hypertens 17:1192-1200
3. Heagerty AM, Aalkjaer C, Bund SJ, Korsgaard N, Mulvany MJ 1993 Small artery structure in hypertension. Dual process of remodeling and growth. Hypertension 21:391-397
4. Rizzoni D, Porteri E, Castellano M, Bettoni G, Muiesan ML, Muiesan P, Giulini SM, Agabiti-Rosei E 1996 Vascular hypertrophy and remodeling in secondary hypertension. Hypertension 28:785-790
5. Rizzoni D, Porteri E, Guefi D, Piccoli A, Castellano M, Pasini G, Muiesan ML, Mulvany MJ, Rosei EA 2000 Cellular hypertrophy in subcutaneous small arteries of patients with renovascular hypertension. Hypertension 35:931-935
6. Rizzoni D, Porteri E, Guelfi D, Muiesan ML, Valentini U, Cimino A, Girelli A, Rodella L, Bianchi R, Sleiman I, Rosei EA 2001 Structural alterations in subcutaneous small arteries of normotensive and hypertensive patients with non insulin dependent diabetes mellitus. Circulation 103:1238-1244
7. Endemann DH, Pu Q, De Ciuceis C, Savoia C, Virdis A, Neves MF, Touyz RM, Schiffrin EL 2004 Persistent remodeling of resistance arteries in type 2 diabetic patients on antihypertensive treatment. Hypertension 43:399-404
8. Schofield I, Malik R, Izzard A, Austin C, Heagerty AM 2002 Vascular structural and functional changes in type 2 diabetes mellitus. Evidence for the role of abnormal myogenic responsiveness and dyslipidemia. Circulation 106:3037-3043
9. Rizzoni D, Porteri E, Giustina A, De Ciuceis C, Sleiman I, Boari GE, Castellano M, Muiesan ML, Bonadonna S, Burattin A, Cerudelli B, Agabiti-Rosei E 2004 Acromegalic patients show the presence of hypertrophic remodeling of subcutaneous small resistance arteries. Hypertension 43:561-565
10. Mulvany MJ 2002 Small artery remodeling and significance in the development of hypertension. News Physiol Sci 17:105-109
11. Rizzoni D, Porteri E, Boari GE, De Ciuceis C, Sleiman I, Muiesan ML, Castellano M, Miclini M, Agabiti-Rosei E 2003 Prognostic significance of small artery structure in hypertension. Circulation 108:2230-2235
12. De Ciuceis C, Porteri E, Rizzoni D, Rizzardi N, Paiardi S, Boari GE, Miclini M, Zani F, Muiesan ML, Donato F, Salvetti M, Castellano M, Tiberio GA, Giulini SM, Agabiti Rosei E 2007 Structural alterations of subcutaneous small arteries may predict major cardiovascular events in hypertensive patients. Am J Hypertens 20:846-852
13. Mathiassen ON, Buus NH, Sihm I, Thybo NK, Mørn B, Schroeder AP, Thygesen K, Aalkjaer C, Lederballe O, Mulvany MJ, Christensen KL 2007 Small artery structure is an independent predictor of cardiovascular events in essential hypertension. J Hypertens 25:1021-1026
14. Mulvany MJ 2007 Small artery structure: time to take note? (editorial commentary). Am J Hypertens 20:853-854
15. Izzard AS, Rizzoni D, Agabiti-Rosei E, Heagerty AM 2005 Small artery structure and hypertension: adaptive changes and target organ damage. J Hypertens 23:247-250
16. Rizzoni D, Muiesan ML, Porteri E, Salvetti M, Castellano M, Bettoni G, Tiberio G, Giulini SM, Monteduro C, Garavelli G, Agabiti-Rosei E 1998 Relations between cardiac and vascular structure in patients with primary and secondary hypertension. J Am Coll Cardiol 32:985-992
17. Rizzoni D, Paiardi S, Rodella L, Porteri E, De Ciuceis C, Rezzani R, Boari GE, Zani F, Miclini M, Tiberio GA, Giulini SM, Rosei CA, Bianchi R, Rosei EA 2006 Changes in extracellular matrix in subcutaneous small resistance arteries of patients with primary aldosteronism. J Clin Endocrinol Metab 91:2638-2642
18. Rossi GP, Bolognesi M, Rizzoni D, Seccia TM, Piva A, Porteri E, Tiberio GA, Giulini SM, Agabiti-Rosei E, Pessina AC 2008 Vascular remodeling and duration of hypertension predict outcome of adrenalectomy in primary aldosteronism patients. Hypertension 51:1366-1371
19. Muiesan ML, Lupia M, Salvetti M, Grigoletto C, Sonino N, Boscaro M, Rosei EA, Mantero F, Fallo F 2003 Left ventricular structural and functional characteristics in Cushing's syndrome. J Am Coll Cardiol 41:2275-2279
20. Fallo F, Budano S, Sonino N, Muiesan ML, Agabiti-Rosei E, Boscaro M 1994 Left ventricular structural characteristics in Cushing's syndrome. J Hum Hypertens 8:509-513
21. Faggiano A, Pivonello R, Spiezia S, De Martino MC, Filippella M, Di Somma C, Lombardi G, Colao A 2003 Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing's disease during active disease and 1 year after disease remission. J Clin Endocrinol Metab 88:2527-2533
22. Albiger N, Testa RM, Almoto B, Ferrari M, Bilora F, Petrobelli F, Pagnan A, Mantero F, Scaroni C 2006 Patients with Cushing's syndrome have increased intimal media thickness at different vascular levels: comparison with a population matched for similar cardiovascular risk factors. Horm Metab Res 38:405-410
23. Walker BR 2007 Glucocorticoids and cardiovascular disease. Eur J Endocrinol 157:545-559
24. Guidelines Committee 2003 European Society of Hypertension- European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 21:1011-1053
25. 1997 Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197
26. Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, Montori VM 2008 The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 93:1526-1540
27. Briones AM, Montoya N, Giraldo J, Vila E 2005 Ageing affects nitric oxide synthase, cyclooxygenase and oxidative stress enzymes expression differently in mesenteric resistance arteries. Auton Autacoid Pharmacol 25:155-162
28. Münzel T, Daiber A, Ullrich V, Mülsch A 2005 Vascular consequences of endothelial nitric oxide synthase uncoupling for the activity and expression of the soluble guanylyl cyclase and the cGMP-dependent protein kinase. Arterioscler Thromb Vasc Biol 25:1551-1557
29. Mollnau H, Schulz E, Daiber A, Baldus S, Oelze M, August M, Wendt M, Walter U, Geiger C, Agrawal R, Kleschyov AL, Meinertz T, Münzel T 2003 Nebivolol prevents vascular NOS uncoupling in experimental hyperlipidemia and inhibits NADPH oxidase activity in inflammatory cells. Arterioscler Thromb Vasc Biol 23:615-621
30. Virdis A, Iglarz M, Neves MF, Amiri F, Touyz RM, Rozen R, Schiffrin EL 2003 Effect of hyperhomocystinemia and hypertension on endothelial function in methylenetetrahydrofolate reductase-deficient mice. Arterioscler Thromb Vasc Biol 23:1352-1357
31. Viel EC, Benkirane K, Javeshghani D, Touyz RM, Schiffrin EL 2008 Xanthine oxidase and mitochondria contribute to vascular superoxide anion generation in DOCA-salt hypertensive rats. Am J Physiol Heart Circ Physiol 295:H281-H288
32. Virdis A, Colucci R, Versari D, Ghisu N, Fornai M, Antonioli L, Duranti E, Daghini E, Giannarelli C, Blandizzi C, Taddei S, Del Tacca M 2009 Atorvastatin prevents endothelial dysfunction in mesenteric arteries from spontaneously hypertensive rats: role of cyclooxygenase 2-derived contracting prostanoids. Hypertension 53:1008-1016
33. Rizzoni D, Palombo C, Porteri E, Muiesan ML, Kozàkovà M, La Canna G, Nardi M, Guelfi D, Salvetti M, Morizzo C, Vittone F, Rosei EA 2003 Relationships between coronary vasodilator capacity and small artery remodeling in hypertensive patients. J Hypertens 21:625-631
34. Porteri E, Rizzoni D, Mulvany MJ, De Ciuceis C, Sleiman I, Boari GE, Castellano M, Muiesan ML, Zani F, Rosei EA 2003 Adrenergic mechanisms and remodeling of subcutaneous small resistance arteries in humans. J Hypertens 21:2345-2352
35. Duprez DA 2006 Role of the renin-angiotensin-aldosterone system in vascular remodeling and inflammation: a clinical review. J Hypertens 24:983-991
36. Pallone TL 2005 Microvascular effects of aldosterone and angiotensin type 2 receptors. Hypertension 45:845-846
37. Schiffrin EL 2006 Effects of aldosterone on the vasculature. Hypertension 47:312-318
38. Molnar GA, Lindschau C, Dubrovska G, Mertens PR, Kirsch T, Quinkler M, Gollasch M, Wresche S, Luft FC, Muller DN, Fiebeler A 2008 Glucocorticoid-related signalling effects in vascular smooth muscle cells. Hypertension 51:1372-1378
39. van den Meiracker AH, Batenburg WW 2008 Corticosteroid-dependent, aldosterone-independent mineralocorticoid-receptor activation in the heart. J Hypertens 26:1307-1309
40. Wang H, Shimosawa T, Matsui H, Kaneko T, Ogura S, Uetake Y, Takenaka K, Yatomi Y, Fujita T 2008 Paradoxical mineralocorticoid receptor activation and left ventricular diastolic dysfunction under high oxidative stress conditions. J Hypertens 26:1453-1462
41. Limbourg FP, Huang Z, Plumier JC, Simoncini T, Fujioka M, Tuckermann J, Schütz G, Moskowitz MA, Liao JK 2002 Rapid nontranscriptional activation of endothelial nitric oxide synthase mediates increased cerebral blood flow and stroke protection by corticosteroids. J Clin Invest 110:1729-1738